Literature DB >> 8003057

Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis.

A D Beaulieu1, S R McColl.   

Abstract

OBJECTIVE: Neutrophils have been shown to produce interleukin-8 (IL-8) and interleukin-1 receptor antagonist (IL-1ra) in large amounts compared with other cytokines. Since IL-8 has a proinflammatory action whereas IL-1ra is antiinflammatory, our objective was to examine the relative levels of production of these cytokines by synovial fluid (SF) neutrophils isolated from patients with rheumatoid arthritis (RA).
METHODS: We measured cytokine production using an enzyme-linked immunosorbent assay and analyzed messenger RNA accumulation in cells by Northern blot.
RESULTS: SF neutrophils produced significantly more IL-8 and IL-1 beta, but significantly less IL-1ra, than peripheral blood neutrophils.
CONCLUSION: These observations provide new information on the production of pro- and antiinflammatory molecules by neutrophils in the SF environment, and their possible role in RA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003057     DOI: 10.1002/art.1780370613

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  Activation of transcription factors and IL-8 expression in neutrophils stimulated with lipopolysaccharide from Porphyromonas gingivalis.

Authors:  N Sugita; A Kimura; Y Matsuki; T Yamamoto; H Yoshie; K Hara
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

2.  Cytotoxic effects of Kingella kingae outer membrane vesicles on human cells.

Authors:  R Maldonado; R Wei; S C Kachlany; M Kazi; N V Balashova
Journal:  Microb Pathog       Date:  2011-04-02       Impact factor: 3.738

3.  Elevated concentrations of interleukin-1 beta and interleukin-1 receptor antagonist in plasma of women with silicone breast implants.

Authors:  E A Ojo-Amaize; O J Lawless; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

4.  Insoluble and soluble immune complexes activate neutrophils by distinct activation mechanisms: changes in functional responses induced by priming with cytokines.

Authors:  G Fossati; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

5.  Lipopolysaccharide-induced interleukin-8 gene expression in human granulocytes: transcriptional inhibition by interferon-gamma.

Authors:  M A Cassatella; S Gasperini; F Calzetti; P P McDonald; G Trinchieri
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

6.  Difference in gene expression of macrophage between normal spleen and portal hypertensive spleen identified by cDNA microarray.

Authors:  Feng Yan; Xiao-Min Wang
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

7.  Interleukin-1 expression by neutrophils in rheumatoid arthritis.

Authors:  J A Quayle; S Adams; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

8.  Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.

Authors:  Lorraine Yeo; Kai-Michael Toellner; Mike Salmon; Andrew Filer; Christopher D Buckley; Karim Raza; Dagmar Scheel-Toellner
Journal:  Ann Rheum Dis       Date:  2011-07-08       Impact factor: 19.103

9.  Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis.

Authors:  Masayoshi Katano; Kazuki Okamoto; Mitsumi Arito; Yuki Kawakami; Manae S Kurokawa; Naoya Suematsu; Sonoko Shimada; Hiroshi Nakamura; Yang Xiang; Kayo Masuko; Kusuki Nishioka; Kazuo Yudoh; Tomohiro Kato
Journal:  Arthritis Res Ther       Date:  2009       Impact factor: 5.156

10.  RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming.

Authors:  Helen L Wright; Huw B Thomas; Robert J Moots; Steven W Edwards
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.